evodiamine (Compound)

Synonyms:Evodiamine, 518-17-2, d-Evodiamine, (+)-Evodiamine, UNII-C01825BVNL, C01825BVNL, CHEBI:4948, (S)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, (1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one, Evodiamine, (+)-, Evodiamine,(S), (13bS)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, MLS006011787, SCHEMBL682158, CHEMBL463165, DTXSID10966123, ZINC898159, BCP02282, HY-N0114, BBL033833, STK801981, AKOS005622478, CS-6161, MCULE-2788564607, (S)-14-methyl-7,8,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one, SMR001934404, VS-12304, N1600, C09187, 518E172, Q-100579, Q27894193, Evodiamine, European Pharmacopoeia (EP) Reference Standard, 14-Methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, (1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE, Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-, Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-

Pubchem:PUBCHEM:151289

Id:fd47e437-8678-58da-82e8-809aa4848f48

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View evodiamine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for evodiamine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with evodiamine.

Results found

Linked to

	Label	Description
	evodiamine (61ba3832-b649-4eb2-8941-43b695417fa5) Collection (Entity type)	Metadatata for evodiamine
	evodiamine positively regulates CSGALNACT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine negatively regulates CHAC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine in similarity relationship with chelidonine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine positively regulates CEACAM7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine negatively regulates SCD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine positively regulates GPD1L Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine negatively regulates PSAT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine negatively regulates DEPP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	evodiamine positively regulates HSPA8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS